Catalyst Wire Dossier Catalyst Wire Dossier

VRELysin

· Intralytix, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for VRELysin, covering 2026-04-14 to 2026-04-14. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy of Oral Administration of the Phage Cocktail, VRELysin™, In Healthy and VRE-Colonized Subjects [Phase 1, Phase 2]

See pricing